These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2928276)

  • 41. Antitrust and hospital privileges. I. Federal jurisdictional requirements.
    Tabor WJ
    JAMA; 1984 May; 251(20):2654-5. PubMed ID: 6716591
    [No Abstract]   [Full Text] [Related]  

  • 42. Antitrust law in the health care field: flux and ferment.
    Bernstein AH
    Hospitals; 1982 Dec; 56(23):13-5. PubMed ID: 7141432
    [No Abstract]   [Full Text] [Related]  

  • 43. Peer review of fees by physician groups: antitrust issues.
    Scott M
    Health Law Vigil; 1986 Jul; 9(14):5-8. PubMed ID: 10277308
    [No Abstract]   [Full Text] [Related]  

  • 44. Physician antitrust case settled.
    Burda D
    Mod Healthc; 1990 Mar; 20(11):5-6. PubMed ID: 10103913
    [No Abstract]   [Full Text] [Related]  

  • 45. Antitrust and health care: a symposium.
    Law Contemp Probl; 1988; 51(2):1-379. PubMed ID: 10295961
    [No Abstract]   [Full Text] [Related]  

  • 46. General Electric may violate antitrust law with purchase of medical imaging business.
    Carter K
    Mod Healthc; 1986 Apr; 16(9):22. PubMed ID: 10276446
    [No Abstract]   [Full Text] [Related]  

  • 47. Health planning and antitrust.
    Laurence K
    Top Health Care Financ; 1984; 10(4):49-59. PubMed ID: 6204419
    [No Abstract]   [Full Text] [Related]  

  • 48. Competition among physicians. Avoiding anticompetitive activities.
    Oliver D
    Consultant; 1988 Dec; 28(12):60-1, 68, 73. PubMed ID: 10290553
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antitrust and hospital peer review.
    Blumstein JF; Sloan FA
    Law Contemp Probl; 1988; 51(2):7-92. PubMed ID: 10295966
    [No Abstract]   [Full Text] [Related]  

  • 50. Trustee involvement in staff appointments: an antitrust Rx.
    Klein RM
    Mich Hosp; 1987 May; 23(5):31-3. PubMed ID: 10281882
    [No Abstract]   [Full Text] [Related]  

  • 51. Antitrust aspects of the future health planning.
    Epstein RL
    Issues Health Care; 1981; 2(1):36-41. PubMed ID: 10253126
    [No Abstract]   [Full Text] [Related]  

  • 52. Antitrust in health care.
    Boland JM
    Colo Med; 1982 Mar; 79(3):116-8. PubMed ID: 6896026
    [No Abstract]   [Full Text] [Related]  

  • 53. Bork's stand on antitrust may change healthcare.
    Kenkel PJ
    Mod Healthc; 1987 Jul; 17(16):69, 71. PubMed ID: 10282817
    [No Abstract]   [Full Text] [Related]  

  • 54. The antitrust perspective on health industry competition.
    Miller FH
    J Health Hum Resour Adm; 1989; 12(1):128-48. PubMed ID: 10296433
    [No Abstract]   [Full Text] [Related]  

  • 55. Court shoots down antitrust immunity.
    Brown M; Nickles PJ
    Mod Healthc; 1982 Aug; 12(8):164-8. PubMed ID: 10256369
    [No Abstract]   [Full Text] [Related]  

  • 56. Antitrust implications for health planning.
    Davis CD
    Tex Hosp; 1984 May; 39(12):59, 61-2. PubMed ID: 10266793
    [No Abstract]   [Full Text] [Related]  

  • 57. Anesthesiology and antitrust law.
    Reilly P
    Resid Staff Physician; 1984 Mar; 30(3):102, 104. PubMed ID: 10265987
    [No Abstract]   [Full Text] [Related]  

  • 58. Avoiding antitrust pitfalls in peer assistance programs.
    Hammaker MK
    J Am Health Care Assoc; 1985 Sep; 11(5):51-2. PubMed ID: 10272795
    [No Abstract]   [Full Text] [Related]  

  • 59. Federal courts review scope of antitrust immunity.
    Moses RJ
    Health Law Vigil; 1982 May; 5(10):suppl 3-4. PubMed ID: 10255187
    [No Abstract]   [Full Text] [Related]  

  • 60. MGMA (Medical Group Management Association) antitrust policy adopted by the MGMA Board of Directors, 1988.
    Med Group Manage J; 1989; 36(3):30. PubMed ID: 10293031
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.